MicroRNA therapeutics and nucleic acid nano-delivery systems in bacterial infection: a review-Reference-Cited by-同舟云学术

MicroRNA therapeutics and nucleic acid nano-delivery systems in bacterial infection: a review

Published:2023 Issue:33 Volume:11 Page:7804-7833
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Li Ze¹²,Lei Zhixin¹²^ORCID,Cai Yilun¹,Cheng Dong-Bing¹²^ORCID,Sun Taolei¹²

Affiliation:

1. School of Chemistry, Chemical Engineering and Life Science, Hospital of Wuhan University of Technology, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China

2. Hubei Key Laboratory of Nanomedicine for Neurodegenerative Diseases, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China

Abstract

In a game of humans versus pathogenic microbes, will MicroRNAs be a key weapon for humans to defeat bacterial infections?

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Natural Science Foundation of Hubei Province

Natural Science Fund for Distinguished Young Scholars of Shandong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB00694H

Reference266 articles.

1. Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study

2. FDA-Approved Oligonucleotide Therapies in 2017

3. COVID-19 and mRNA Vaccines—First Large Test for a New Approach

4. Patisiran: First Global Approval

5. RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT Mice

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking novel therapeutic avenues in glioblastoma: Harnessing 4-amino cyanine and miRNA synergy for next-gen treatment convergence;Neuroscience;2024-08

2. A Review of Nanotechnology in microRNA Detection and Drug Delivery;Cells;2024-07-30

3. Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment;Pharmaceuticals;2024-07-10